Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Asian Journal of Endoscopic Surgery|December 16, 2016
Prospective registry for laparoscopic liver resectionHiroaki Fuji, Etsuro Hatano, Satoru Seo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using 18F-Fluorodeoxyglucose Positron Emission TomographyTakayuki Kawai, Kentaro Yasuchika, Satoru Seo, et al.
Surgery|August 14, 2022
Impact of anatomical liver resection on patient survival in KRAS-wild-type colorectal liver metastasis: A multicenter retrospective studyTakayuki Kawai, Takamichi Ishii, Yoichiro Uchida, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|August 27, 2014
Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survivalMasayuki Okuno, Etsuro Hatano, Satoru Seo, et al.
Cancer Science|July 28, 2020
A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinomaMasatoshi Kudo, Manabu Morimoto, Michihisa Moriguchi, et al.
Surgery|December 2, 2025
Optimal strategies for surgical resection of pancreatic body cancer: A multi-institutional cohort studyAsahi Sato, Takayuki Anazawa, Kazuyuki Nagai, et al.
Cancer Chemotherapy and Pharmacology|September 3, 2010
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancerMasashi Kanai, Kenichi Yoshimura, Takehiko Tsumura, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|May 1, 2015
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)Etsuro Hatano, Masayuki Okuno, Kojiro Nakamura, et al.
International Journal of Clinical Oncology|October 19, 2016
Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancersSatoshi Nagayama, Suguru Hasegawa, Koya Hida, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|May 4, 2020
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survivalMasayuki Okuno, Etsuro Hatano, Rei Toda, et al.
Pageof 9